top of page

HELP 4 HD INTERNATIONAL

New Resource Database is Live 🎉 Click Here

Search

katrina4384

Sep 14, 20231 min read

Neurocrine Biosciences

Neurocrine Biosciences Announces U.S. FDA Accepts New Drug Application for INGREZZA (valbenazine) Oral Granules Sprinkle Formation

Recent Posts

uniQure Announces Alignment with FDA on Key Elements of Accelerated Approval Pathway for AMT-130 in Huntington’s Disease

Holiday gift-giving ideas for someone with advanced HD

PTC Therapeutics Enters into a Global License and Collaboration Agreement with Novartis for PTC518 Huntington's Disease Program

Comments

bottom of page